Goldman Sachs Updates Illumina Estimates

Goldman Sachs is updating its Illumina Inc. ILMN estimates to reflect “our latest sequencing system placement assumptions for both HiSeq and MiSeq for 2011-2014.” “We now believe the mix will shift more towards MiSeq than HiSeq and as a result our 2011-2013 EPS estimates go to $1.55, $2.04, $2.64 from $1.55, $2.08, $2.70, respectively,” Goldman Sachs writes. Illumina closed Thursday at $74.13.